Key result
Advanced PET hardware and radiotracers support diagnosis, treatment monitoring, and risk stratification in inflammatory cardiac diseases.
Recent advances in PET imaging hardware and radiotracers expand its utility in inflammatory cardiac diseases beyond diagnosis to treatment monitoring and risk stratification.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for broader PET molecular imaging in cardiac inflammation; leaves open routine adoption pending standardization and histologic validation.
F]FDG)-based approach toward a broader molecular imaging platform that combines technical innovation with tracer diversification. This review summarizes recent advances in PET imaging of inflammatory cardiac disease, including new hardware and promising new radiotracers. Current evidence supports PET as a tool not only for diagnosis but also for treatment monitoring and risk stratification, and future progress will depend on standardization, histologic validation, and integration of advanced hardware, disease-specific tracers, and multimodality biomarkers into clinically actionable pathways.
No takes yet. Share an insight, caveat, or question.
Bund et al. (2026) conducted a review in Inflammatory cardiac diseases. PET imaging was evaluated. PET imaging for inflammatory cardiac diseases is advancing with new hardware and radiotracers, supporting its utility for diagnosis, treatment monitoring, and risk stratification.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: